About Gebro Pharma
Gebro Pharma: A Pioneer in Independent Research and Development in the Pharmaceutical Industry
For over 70 years, Gebro Pharma has been a leading player in the pharmaceutical industry, renowned for its independent research and development. The company's unwavering commitment to innovation and excellence has made it a trusted name among healthcare professionals and patients alike.
Founded in Austria in 1949, Gebro Pharma has grown into a global enterprise with operations spanning Europe, Asia, Africa, and South America. The company's success can be attributed to its focus on developing high-quality medicines that meet the needs of patients worldwide.
Gebro Pharma's research efforts are centered around finding new treatments for diseases that have yet to be adequately addressed by existing therapies. The company's team of scientists works tirelessly to identify novel drug targets and develop innovative formulations that can improve patient outcomes.
One of Gebro Pharma's key strengths is its ability to leverage cutting-edge technologies to accelerate drug discovery and development. The company invests heavily in state-of-the-art equipment and facilities that enable its researchers to conduct experiments with greater precision and efficiency.
In addition to its research activities, Gebro Pharma is also committed to ensuring that its products are manufactured according to the highest quality standards. The company operates several manufacturing facilities around the world that adhere strictly to Good Manufacturing Practice (GMP) guidelines.
Gebro Pharma offers a wide range of products across various therapeutic areas such as pain management, respiratory diseases, cardiovascular disorders, gastroenterology, neurology & psychiatry as well as oncology & hematology. Some of their most popular products include:
- Tilcitin®: A non-opioid analgesic used for moderate-to-severe pain relief.
- Bronchicum®: A herbal cough syrup used for symptomatic relief from coughs associated with colds or bronchitis.
- Cardiloc®: A calcium channel blocker used for hypertension treatment.
- Pantoprazol Gebro®: A proton pump inhibitor used for acid-related disorders like GERD or peptic ulcers.
- Temozolomide Gebro®: An oral chemotherapy agent indicated for glioblastoma multiforme treatment.
At Gebro Pharma they believe it is important not only develop new drugs but also ensure accessability so they offer affordable prices without compromising quality which makes them stand out from other pharmaceutical companies who often charge exorbitant prices making their drugs unaffordable especially in developing countries where accessability is crucially important.
In conclusion,Gebro pharma stands out among other pharmaceutical companies due their commitment towards independent research ,innovation ,quality assurance ,accessibility at affordable prices .Their dedication towards improving patient outcomes through novel drug discovery makes them an invaluable asset within the healthcare industry .